Hyderabad, India, July 2026 — Biological E. Limited has appointed Anumeha Srivastava as Chief Executive Officer – Digital Health Joint Venture, marking a significant step in the company’s expansion into AI-enabled healthcare and digital innovation. In her new role, she will lead the joint venture’s strategic direction, leveraging advanced digital technologies and artificial intelligence to build the next generation of healthcare solutions.
Anumeha joins Biological E. after an accomplished six-year leadership journey at Qure.ai, where she most recently served as Chief Business Officer. During her tenure, she played a pivotal role in accelerating the company’s global commercial growth, expanding AI-powered healthcare solutions, and strengthening partnerships with healthcare providers across international markets. Prior to becoming Chief Business Officer, she served as Chief Customer Officer, overseeing customer success and driving adoption of AI solutions that enhanced clinical outcomes and operational excellence.
Earlier at Qure.ai, Anumeha served as Vice President – Head of Client Success, where she led client engagement across the UK, Europe, Asia-Pacific, and the Middle East & Africa, helping healthcare organizations transform clinical workflows through AI-enabled digital imaging solutions. She also served as Vice President – Client Success & Operations, building scalable customer success operations and supporting the organization’s rapid global expansion.
Before entering the AI healthcare space, Anumeha worked with Max Healthcare in Product & Operations, where she gained extensive experience in healthcare operations, product management, and patient-centric service delivery. She also led program management initiatives at The Ganga Trust, designing inclusive education, employment, and sports programs for people with spinal cord injuries while successfully leading fundraising and social impact initiatives.
Anumeha began her professional career as a Medical Professional at Christian Medical College (CMC), Vellore, providing patient care, community outreach, rehabilitation support, research, and chronic disease management, giving her a strong clinical foundation that continues to shape her approach to healthcare innovation.
She holds an MBA in Strategy and Marketing from the Indian School of Business (ISB), where she received the Inaugural Godrej Parmeshwar Award for Social Impact and the Young Leader Award, and served as President of the Net Impact Club.
Combining medical expertise, business leadership, AI-enabled healthcare innovation, digital transformation, and global commercial experience, Anumeha is exceptionally well positioned to lead Biological E.’s Digital Health Joint Venture as it develops innovative technology-driven healthcare solutions for the future.
About Biological E. Limited
Founded in 1953, Biological E. Limited is India’s first private-sector biological products company and one of the world’s leading vaccine manufacturers. Having supplied more than 2 billion vaccine doses globally, the company provides life-saving vaccines and pharmaceuticals to UNICEF, PAHO, national immunization programs, governments, armed forces, and healthcare providers worldwide. Biological E. continues to advance equitable access to quality vaccines, therapeutics, and innovative healthcare solutions through scientific excellence and continuous innovation.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
